Global nuclear medicine market
Dublin, Dec. Feb. 22, 2022 (GLOBE NEWSWIRE) — The “Global Nuclear Medicine Market Report 2022: Impact of Ukraine-Russia War” report has been added to from ResearchAndMarkets.com offer.
The global nuclear medicine market is expected to grow from $6.00 billion in 2021 to $6.77 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The nuclear medicine market is expected to reach $11.20 billion in 2026 at a CAGR of 13.4%.
The main types of nuclear medicine are diagnostic and therapeutic. A diagnosis is an examination to identify a person’s strengths and weaknesses in order to identify a condition, illness or disease. Applications were in Cardiology, Lymphoma, Thyroid, Neurology, Oncology and other applications. End users included hospitals and clinics, diagnostic centers and other end users.
North America was the largest region in the nuclear medicine market in 2021. Asia-Pacific is expected to be the fastest growing region during the forecast period. Regions covered in this Nuclear Medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The growing consistency and prevalence of cardiovascular disease (CVD) and cancer is expected to propel the growth of the nuclear medicine market in the future. Cardiovascular disease (CVD) is a group of heart and vascular disorders, and cancer is a disease in which cells grow out of control and spread to other parts of the body. Nuclear heart imaging can help diagnose heart disease more quickly. Nuclear medicine therapy is a method of treating cancer that can be used with or after other treatment options, such as surgery and chemotherapy.
As a result, the growing pattern and prevalence of cardiovascular disease and cancer is increasing the demand for the nuclear medicine market. For example, in 2020, according to GLOBOCAN, a US-based cancer observatory, there were 19.29k new cancer cases globally in 2020, and 28.88k cases are predicted by 2040. Additionally, in 2019, according to the World Health Organization (WHO), a Switzerland-based international public health organization, estimates that 17.9 million people worldwide died from cardiovascular disease. (CVD) in 2019, representing 32% of all deaths. 85% of these deaths were caused by heart attack and stroke. Hence, the growing consistency and prevalence of cardiovascular disease and cancer is driving the nuclear medicine market.
Product innovation is the key trend gaining popularity in the nuclear medicine market. Major companies operating in the nuclear medicine market are focusing on developing new innovative products to strengthen their position.
For example, in March 2021, GE Healthcare, an American nuclear medicine company, launched Star Guide, a new nuclear medicine system to help advance precision health and theranostics. StarGuide uses the latest developments in Cadmium Zinc Telluride (CZT) technology to help providers explore and better understand patient status, improving patient outcomes across the continuum of care. It has unique features such as digital focus detectors and 360-degree system imaging that are intended to support enhanced nuclear medicine theranostic capabilities and advanced precision health.
|
Report attribute |
Details |
|
No. of pages |
175 |
|
Forecast period |
2022 – 2026 |
|
Estimated market value (USD) in 2022 |
$6.77 billion |
|
Expected market value (USD) by 2026 |
$11.2 billion |
|
Compound annual growth rate |
13.4% |
|
Regions covered |
Overall |
Reasons to buy
-
Get a truly global perspective with the most comprehensive report available on this market covering over 12 geographies.
-
Understand how the market is affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus diminishes.
-
Russia Assessment – Impact of war on the supply of agricultural, energy and mineral products and their direct and indirect impact on the market analyzed in the report.
-
Impact of high global inflation on market growth.
-
Create regional and national strategies based on local data and analysis.
-
Identify growth segments for investment.
-
Outperform your competition using forecast data and the drivers and trends shaping the market.
-
Understand customers based on the latest market research.
-
Benchmark performance against leading competitors.
-
Use relationships between key data sets for better strategy.
-
Suitable to support your internal and external presentations with reliable high quality data and analysis
-
All report data will also be delivered in Excel format.
Scope
Covered market :
1) By Type: Diagnostic; Therapeutic
2) By application: Cardiology; lymphoma; Thyroid; Neurology; Oncology; other app
3) By end user: hospitals and clinics; Diagnostic centers; Other end users
Main topics covered:
1. Summary
2. Characteristics of the Nuclear Medicine Market
3. Nuclear Medicine Market Trends and Strategies
4. Nuclear Medicine Market – Macroeconomic Scenario
5. Nuclear Medicine Market Size and Growth
6. Nuclear Medicine Market Segmentation
7. Regional and Country Analysis of Nuclear Medicine Market
8. Asia Pacific Nuclear Medicine Market
9. Chinese Nuclear Medicine Market
10. Indian Nuclear Medicine Market
11. Japan Nuclear Medicine Market
12. Australia Nuclear Medicine Market
13. Indonesia Nuclear Medicine Market
14. South Korea Nuclear Medicine Market
15. Western Europe Nuclear Medicine Market
16. UK Nuclear Medicine Market
17. Germany Nuclear Medicine Market
18. Nuclear medicine market in France
19. Eastern Europe Nuclear Medicine Market
20. Russian nuclear medicine market
21. North America Nuclear Medicine Market
22. US Nuclear Medicine Market
23. South America Nuclear Medicine Market
24. Brazil Nuclear Medicine Market
25. Middle East Nuclear Medicine Market
26. Africa Nuclear Medicine Market
27. Nuclear Medicine Market Competitive Landscape and Company Profiles
28. Major mergers and acquisitions in the nuclear medicine market
29. Nuclear Medicine Market Future Outlook and Potential Analysis
30. Annex
Companies cited
-
Bracco Imaging Spa
-
Lantheus Medical Imaging Inc.
-
NTP Radioisotopes SOC Ltd
-
Eckert & Ziegler Group
-
Jubilant Pharma LLC
-
Australian Nuclear Science and Technology Organization
-
Cardinal Health Inc.
-
GE Healthcare
-
Curium Pharma7
-
Advanced Accelerator Applications
-
Nordion Inc.
-
The Institute of Radioelements
-
Eczacibasi-monrol
-
Siemens Healthineers AG
-
Cambridge Isotope Laboratories Inc.
For more information on this report, visit https://www.researchandmarkets.com/r/mb0gr9
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
0 Comments